Literature DB >> 29202349

Chondrometaplasia of the vocal cord in an adult male.

Hamoud AlArouj1, Abdulmohsen Kamel AlBader2, Imtiyaz Nawaz Bhat1.   

Abstract

INTRODUCTION: (Chondrometaplasia of the larynx is a rare disease. We report a case that presented at the otolaryngology department in our institute in 2015.) PRESENTATION OF CASE: A 62year old man without any history of trauma presented with progressive dysphonia, dyspnoea, without any dysphagia. A fibreoptic laryngoscopic examination revealed nodular mass arising at the junction of anterior 1/3rd and posterior 2/3rd of left vocal cord. DISCUSSION: A computed tomography scan of the neck region showed a rounded and circumscribed mass without infiltration of the surrounding tissues. Histological investigation of the lesion revealed the presence of fibroelastic cartilaginous tissue, surrounded by a thin rim of fibrous tissue, with rare hypercellular areas, occasional binucleated cells, slight hyperchromasia, and an irregular nuclear profile. Mitotic activity was absent.
CONCLUSION: The patient didn't have history of laryngeal trauma. Subacute and progressive onset of clinical symptoms and histological and radiological findings helps to distinguish the chondrometaplastic nature from true laryngeal cartilaginous tumours, such as chondroma and low grade chondrosarcoma.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cartilaginous tumour; Chondrometaplasia; Larynx

Year:  2017        PMID: 29202349      PMCID: PMC5723368          DOI: 10.1016/j.ijscr.2017.11.029

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Chondrometaplasia of larynx is a rare entity with an unknown etiopathogenesis [1], [2]. The lesion remains asymptomatic unless it reaches a large size and a history of trauma is usually elicited. It is a known pitfall in diagnostic evaluation and a clinically significant differential considered in evaluation of cartilaginous tumours of the larynx [4], [5]. Nodular chondrometaplasia can arise in laryngeal tissues, but very rarely becomes clinically relevant [6]. A patient’s history of laryngeal trauma has been reported in literature Histopathology and Computed Tomography and MRI helps to differentiate chondrometaplasia from true cartilaginous tumours, such as chondroma and low grade chondrosarcoma [7]. The patient was first evaluated using an endoscopy (Fig. 1, Fig. 2).
Fig. 1

Glottis during adduction.

Fig. 2

Fully abducted position. Small swelling at the junction of the anterior 1/3 and posterior 2/3 of the left vocal fold, interartenoid congested mucosa.

Glottis during adduction. Fully abducted position. Small swelling at the junction of the anterior 1/3 and posterior 2/3 of the left vocal fold, interartenoid congested mucosa. The work has been reported in line with SCARE criteria [8].

Pathology

Histologically, chondrometaplasia is typically characterised by a peripheral fibroblastic rim, with a transition to mature chondrocytes of the fibroelastic cartilage towards the centre of the nodule. Chondrometaplasia also shows a fibroblastic proliferation with stromal myxoid changes and the appearance of lacunae, simulating the hyaline cartilage typical of true cartilaginous tumours. “Elastophilia” of collagen bundles in the centre of cartilaginous nodules is uncommon [3] (Fig. 3, Fig. 4).
Fig. 3

Computed tomographic scan of patient showing features of nodular chondrometaplasia.

Fig. 4

Microscopic Examination shows a thin fibrous rim at the periphery of the elastic cartilage nodule, features compatible with chondrometaplasia.

Computed tomographic scan of patient showing features of nodular chondrometaplasia. Microscopic Examination shows a thin fibrous rim at the periphery of the elastic cartilage nodule, features compatible with chondrometaplasia.

Discussion and review of literature

There are only a few reports on laryngeal chondrometaplasia in the literature, although a postmortem study revealed that microscopic foci of metaplastic cartilage may be found in about 1–2% of all examined larynges. This discrepancy derives from the fact that such lesions are usually small (usually less than 1 cm in diameter) and asymptomatic, so that surgical treatment is rarely needed. Laryngeal chondrometaplasia shows a predilection for the posterior and midportions of the glottis, and for the ventricular bands. The recognition of nodular chondrometaplasia is important because of its occasionally troublesome differential diagnosis from true cartilaginous neoplasms of the larynx, such as chondroma and low grade chondrosarcoma. The imaging appearance of this uncommon disease is even more rarely described. There are only two case reports describing its appearances in computed tomography (CT) and magnetic resonance imaging (MRI). Ultrasound (US) features have not been reported so far. The clinical presentation of laryngeal chondrometaplasia is similar to the other laryngeal tumours. The symptoms include hoarseness, dyspnea, dysphagia or vocal fold palsy. It is postulated that previous laryngeal trauma or laryngo-tracheitis predisposes to the development of metaplasia in the larynx. It is also suggested that the presence of these predisposing factors with progressive onset of symptoms may help in recognizing the chondrometaplastic nature of the lesion and distinguishing it from true laryngeal cartilaginous tumours which usually have no triggering factors. Microscopic Laryngeal Examination (MLS) and Local excision of the lesion under G/A is all that is needed and patient should be Instructed properly against post op. voice abuse and if facilities are available a must post op. voice therapist consultation should be sought and long term follow up is also must in order to rule out any recurrence.

Conclusion

“The recognition of chondrometaplasia is important because of its occasionally troublesome differential diagnosis from true cartilaginous neoplasms of the larynx, such as chondroma and low grade chondrosarcoma”.

Conflicts of interest

No conflict of interest to declare by any of the authors.

Funding

No sources of funding for our research.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available and can be provided whenever needed.

Author contribution

Dr Abdulmohsen; data collection, writing the paper. Dr Hamoud; data analysis and contribution. Dr Imtiyaz: data collection, writing paper, study concept.

Registration of research studies

researchregistry3025.

Guarantor

Dr Abdulmohsen and Dr Imtiyaz.
  7 in total

1.  Chondrometaplasia of the larynx.

Authors:  R E Fechner
Journal:  Arch Otolaryngol       Date:  1984-08

2.  Cartilaginous metaplasia of soft tissues in the larynx. Case report and literature review.

Authors:  P V Iyer; P V Rajagopalan
Journal:  Arch Otolaryngol       Date:  1981-09

3.  [Benign chondroma of the thyroid cartilage. Apropos of a case].

Authors:  P Mendes da Costa; W Smets
Journal:  Acta Chir Belg       Date:  1977 Nov-Dec       Impact factor: 1.090

4.  Chondroid tumors of the larynx: computed tomography findings.

Authors:  S J Wang; A Borges; R B Lufkin; J A Sercarz; M B Wang
Journal:  Am J Otolaryngol       Date:  1999 Nov-Dec       Impact factor: 1.808

Review 5.  Cartilaginous tumors of the larynx.

Authors:  K O Devaney; A Ferlito; C E Silver
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-03       Impact factor: 1.547

6.  Chondromatous metaplasia in the human larynx.

Authors:  M J Hill; C L Taylor; G B Scott
Journal:  Histopathology       Date:  1980-03       Impact factor: 5.087

7.  Chondrometaplasia of the larynx.

Authors:  A Ferlito; G Recher
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1985       Impact factor: 1.538

  7 in total
  1 in total

1.  Differing characteristics of cartilaginous lesions of the larynx.

Authors:  Alfio Ferlito; Kenneth O Devaney; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-23       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.